Skip to main content
View Cart

Journals in Oncology

BooksJournals

  • Journal of Geriatric Oncology

    • ISSN: 1879-4068
    The Journal of Geriatric Oncology is an international, multidisciplinary journal which is focused on advancing research in the treatment and survivorship issues of older adults with cancer, as well as literature relevant to education and policy development in geriatric oncology.Editor-in-C... Supriya Mohile, University of Rochester, USA and the Editorial Board invite you to submit a manuscript to the Journal of Geriatric Oncology. The journal welcomes the submission of manuscripts in the following categories:• Original research articles • Review articles • Clinical trials • Education and training articles • Short communications • Perspectives • Meeting reports • Letters to the EditorThe Journal of Geriatric Oncology is the official journal of the International Society of Geriatric Oncology (SIOG).Journal of Geriatric Oncology's Inclusion and Diversity Pledge This journal pledges to maintain diversity on the editorial team. This sits within Elsevier's broader?ongoing inclusion & diversity efforts. Equity and inclusion in publishing is critically important for scientific excellence and innovation. We believe passionately in the power of an inclusive publishing environment, not only to do what is right, but to enrich, strengthen and advance us all.
    Subscriptions

  • Journal of Thoracic Oncology

    • ISSN: 1556-0864
    Official Journal of the International Association for the Study of Lung CancerAbout the JournalJournal of Thoracic Oncology (JTO), the official journal of the International Association for the Study of Lung Cancer, is the primary educational and informational publication for topics relevant to the prevention, detection, diagnosis, and treatment of all thoracic malignancies. JTO emphasizes a multidisciplinary approach and includes original research reviews and opinion pieces. The audience includes epidemiologists, medical oncologists, radiation oncologists, thoracic surgeons, pulmonologists, radiologists, pathologists, nuclear medicine physicians, and research scientists with a special interest in thoracic oncology. The journal is interested in receiving manuscripts dealing with epidemiology, prevention, screening, early detection, staging, cure, and treatment of thoracic malignancies. Submissions on tobacco control and cessation are of interest, particularly where there is direct relevance to lung cancer epidemiology and therapeutic outcomes. The Journal also welcomes submissions on pathologic and histologic classification and novel imaging and bronchoscopic approaches. Submissions regarding novel systemic therapies, particularly in the fields of biomarker targets, genomics, immunology, and cellular therapies are of interest. Novel radiotherapy and surgical techniques are of interest. Submission of randomized phase II and phase III trials, as well as meta analyses of individual participant data, are encouraged. Basic science studies must have direct clinical and translational relevance.Authors are also welcome to submit to the journal's open access companion title, JTO Clinical and Research Reports, which welcomes a range of manuscripts from subset analyses of published trials to high-quality case reports.
    Subscriptions

  • Cancer Treatment Reviews

    • ISSN: 0305-7372
    Cancer Treatment Reviews is an international journal that provides state of the art, authoritative review articles to the clinician and researcher to keep them abreast of modern concepts and the latest developments in cancer treatment research.Journal of Cancer Treatment Reviews' Inclusion and Diversity PledgeThis journal pledges to maintain diversity on the editorial team. This sits within Elsevier's broader ongoing inclusion & diversity efforts. Equity and inclusion in publishing is critically important for scientific excellence and innovation. We believe passionately in the power of an inclusive publishing environment, not only to do what is right, but to enrich, strengthen and advance us all.
    Subscriptions

  • Critical Reviews in Oncology/Hematology

    • ISSN: 1040-8428
    Official Journal of the European School of Oncology (ESO) and the International Society of Liquid Biopsy.Critical Reviews in Oncology/Hematology publishes scholarly, critical reviews in all fields of oncology and hematology written by experts from around the world.The journal considers articles on the following themes:Basic Experimental OncologyCareer Development and Education in OncologyClinical ResearchHematologyIm... Pathology, Genomics and omics, and Liquid BiopsyPalliative SupportPediatric OncologyRadiotherapy... Ethics, and Health PolicySolid TumorsStatistics, Meta-analysis, and Clinical Trial DesignSurgeryCritica... Reviews in Oncology/Hematology is the Official Journal of the European School of Oncology (ESO) and the International Society of Liquid Biopsy (ISLB).All review articles, invited or submitted spontaneously, are subject to peer review before final acceptance. Further information regarding the submission of manuscripts and guidelines for the preparation of the manuscripts can be found in the Guide for Authors.
    Subscriptions

  • Medical Dosimetry

    • ISSN: 0958-3947
    Official Journal of the American Association of Medical DosimetristsMedical Dosimetry, the official journal of the American Association of Medical Dosimetrists, is the key source of information on new developments for the medical dosimetrist. Practical and comprehensive in coverage, the journal features original contributions and review articles by medical dosimetrists, oncologists, physicists, and radiation therapy technologists on clinical applications and techniques of external beam, interstitial, intracavitary and intraluminal irradiation in cancer management. Articles dealing primarily with physics will be reviewed by a specially appointed team of experts in the field.
    Subscriptions

  • Clinical Genitourinary Cancer

    • ISSN: 1558-7673
    Clinical Genitourinary Cancer is a peer-reviewed journal that publishes original articles describing various aspects of clinical and translational research in genitourinary cancers. Clinical Genitourinary Cancer is devoted to articles on detection, diagnosis, prevention, and treatment of genitourinary cancers. The main emphasis is on recent scientific developments in all areas related to genitourinary malignancies. Specific areas of interest include clinical research and mechanistic approaches; drug sensitivity and resistance; gene and antisense therapy; pathology, markers, and prognostic indicators; chemoprevention strategies; multimodality therapy; and integration of various approaches.
    Subscriptions

  • Seminars in Oncology

    • ISSN: 0093-7754
    Seminars in Oncology brings you current, authoritative, and practical articles on advances in the etiology, diagnosis and management of cancer. The journal is dedicated to providing both the basic knowledge needed to better understand cancer-related subjects as well as evidence-based perspectives from leaders in the field. Seminars in Oncology also seeks to be a venue for sharing diverse viewpoints, including innovative and unconventional ideas that might be considered "outside the box". We encourage a healthy, constructive and respectful exchange of opinions and welcome your insights as well as suggestions for topics worthy of coverage. By deepening readers understand of the basic biology and therapy of cancer through expert insights, and by fostering an open exchange of ideas, Seminars in Oncology aims to advance the science and practice of cancer care.
    Subscriptions

  • Mutation Research: Reviews in Mutation Research

    • ISSN: 1383-5742
    The subject areas of Mutation Research - Reviews in Mutation Research (MRR) encompass the entire spectrum of the science of mutation research and its applications, with particular emphasis on the relationship between mutation and disease. Thus, this section will cover:Advances in human genome research (including evolving technologies for mutation detection and functional genomics) with applications in clinical genetics, gene therapy and health risk assessment for environmental agents of concernGenetic toxicology and environmental mutagenesis (including the factors that modulate the genetic activity of environmental agents) will continue to be prominent topics in this section.MRR supports and follows the general direction proposed by all major societies in the field part of the International Association of Environmental Mutagenesis and Genomics Societies (IAEMGS):Asociacion Latinoamericana de Mutagenesis, Carcinogenesis y Teratogenesis Ambiental (ALAMCTA)Brazilian Association of Mutagenesis and Environmental Genomics (MutaGen-Brasil)Chin... Environmental Mutagen Society (CEMS)European Environmental Mutagenesis and Genomics Society (EEMGS)Environmental Mutagenesis and Genomics Society (EMGS)Environmental Mutagen Society of India (EMS India)Iranian Environmental Mutagen Society (IrEMS)The Japanese Environmental Mutagen Society (JEMS)Korean Environmental Mutagen Society (KEMS)Molecular and Experimental Pathology Society of Australasia (MEPSA)Pan-African Environmental Mutagen Society (PAEMS)Philippines Environmental Mutagen Society (PEMS)Thai Environmental Mutagen Society (TEMS)Other Mutation Research sections: DNA Repair Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis (MR) Mutation Research - Genetic Toxicology and Environmental Mutagenesis (MRGTEM)
    Subscriptions

  • Cytotherapy

    • ISSN: 1465-3249
    Cytotherapy, the official journal of the International Society for Cell & Gene Therapy (ISCT), publishes novel and innovative results from high quality scientific and clinical studies in the fields of cell, gene, and extracellular vesicle therapy.Cytotherapy considers manuscripts exploring the following topics:Development and/or characterization of novel gene therapies and cell and/or EV-based therapeutics.Design of novel therapeutic approaches employing cell/EV/gene products.Scientific mechanisms of action of cell/EV/gene therapies in relevant cell-based and pre-clinical models.Scientific mechanisms of action of toxicities attributable to cell/EV/gene therapiesIdentificat... of novel biomarkers that predict the potency of cell/EV/gene therapies and/or stratify patients based on response rates.Early and late phase clinical studies evaluating the safety and efficacy of cell/EV/gene therapies.Important advances in cell/EV/gene-based product manufacturing and validation.Global/re... regulatory practices that impact the authorized use and/or regulatory approval of cell/EV and gene therapies.Cytotherap... does not publish manuscripts on the following topics:Case studies unless they are of unusual significance to the field.Basic/translat... studies exploring the role of lncRNAs, circRNAs, and miRNAs in disease pathophysiology.Fund... scientific studies of normal or pathological processesStudies describing signaling pathways implicated in cancer.
    Subscriptions

  • Cytokine & Growth Factor Reviews

    • ISSN: 1359-6101
    Cytokine & Growth Factor Reviews publishes thought-provoking articles (critical reviews, state-of-the-art reviews, letters to the editor, meeting reviews) devoted to important advances in the rapidly changing fields of growth factor and cytokine research. Major emphasis is placed on the multidisciplinary significance of cytokines and growth factors in areas as diverse as signal transduction, cell growth and differentiation, embryonic development, immunology, tumorigenesis and clinical medicine.Benefits to authors We also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services.Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our Support Center
    Subscriptions